Breast Ductal Carcinoma In Situ Clinical Trials
27 clinical trials for Breast Ductal Carcinoma In Situ across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Neoadjuvant Breast Cancer Time Restricted Eating — RECRUITING · PHASE2
- Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction — RECRUITING · PHASE2
- Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial — RECRUITING · PHASE2
- Identifying and Caring for Individuals With Inherited Cancer Syndrome — RECRUITING · NA
- Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer — RECRUITING · PHASE2
- A Novel Fluorescent Ductal Needle for Localization and Sampling of Micro Lesions in Breast Ducts — RECRUITING · NA
- Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery — RECRUITING
- A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ — RECRUITING · PHASE1
- A Patient Navigation Program for Addressing Disparities in Breast Cancer Care — RECRUITING · NA
- Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer — RECRUITING · NA
- Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial — SUSPENDED · PHASE3
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE3
- High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer — SUSPENDED · PHASE2
- Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial — TERMINATED · PHASE2
- Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery — ACTIVE_NOT_RECRUITING · PHASE1
- Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE1
- Metformin and Nightly Fasting in Women With Early Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
- Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer — TERMINATED · PHASE2
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy — COMPLETED · PHASE3
- EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer — COMPLETED · NA
- An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors — COMPLETED · NA
- Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study — ACTIVE_NOT_RECRUITING · PHASE2
- Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer — TERMINATED · PHASE1
- Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer — COMPLETED · PHASE2
- Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer — COMPLETED · NA
- Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer — COMPLETED · PHASE1
- Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ — OTHER · PHASE3
Refine this search